German Exhibition Health Zhang Yong: Professional Advantages Help Epidemic Prevention And Control Practice Corporate Social Responsibility

At the beginning of 2020, a sudden outbreak of pneumonia affected the nerves of the Chinese people. In the fight against pneumonia, enterprises from all walks of life have made a lot of contributions to support Wuhan in different ways.

Some enterprises participate in the distribution of relief materials in seconds, and some enterprises need to work overtime to increase production and material support. Some enterprises mobilize all strength donations and donations, and send them to the front line through different channels. Some enterprises take the initiative to make profits and support the development of small and medium-sized enterprises.

For listed companies, the public attribute is becoming more and more prominent, and the value of public trust capital is becoming more and more prominent. Such values come from many aspects, such as customer service concept, capital market awareness, environment and sustainable development strategy, and of course, the response of enterprises to major emergencies.

Public trust capital is not only a booster for development, but also a "fuse" for its own crisis.

The "elite" reporter interviewed a number of listed company leaders, who made their respective contributions in different ways, which is a solid "enterprise strength" in the fight against the epidemic.

Germany exhibition health professional advantages help epidemic prevention and control

Since the outbreak of the new crown pneumonia in January 2020, the German listed health company as a pharmaceutical company has persisted in carrying out corporate social responsibility, fully exerting its own professional advantages and actively participating in the war epidemic.

Zhang Yong, director of Health Exhibition, said in an exclusive interview with "excellence" reporter, Zhang Yong personally led the formation of the high-level response team of the epidemic company, and was always on call during the whole Spring Festival holiday, always paying attention to the development of the epidemic situation and strictly implementing the company's epidemic response measures.

In January 27, 2020, it was learned that the Hubei area urgently needed anti epidemic materials and personnel. The first time for the German health exhibition was to rush to Hubei to donate 5 million yuan disinfectant material to the Red Cross Society of Hubei Province, which was specially used to help Hubei province carry out epidemic prevention and control.

At the same time, Germany exhibition is working hand in hand to draw up acquiring company Changjiang Mai medicine, and fully supports the Yangtze River pulse to expand its capacity urgently and ensure emergency supply. Beijing Changjiang Mai Pharmaceutical Technology Co., Ltd. is a leading enterprise in China for disinfection. It has more than 20 years of professional experience in infectious disease prevention and control.

Disinfection is an important means to cut off the transmission route of new crown virus, and is the top priority of epidemic prevention and control. The Yangtze River medicine has received a large number of demand plans from many health administrative departments, CDC, medical institutions, distributors and so on. In order to meet these needs, Germany exhibition health emergency assistance to solve the problem of capital shortfall in the Yangtze River expansion, and signed an agreement on that day to pay 50 million yuan for the expansion of the Yangtze River pulse company.

"The German exhibition health and the Changjiang River are working together to expand production capacity urgently, and strive to ensure maximum supply and maximize social responsibility." Zhang Yong told the "elite" reporter that the main production plant of the Yangtze River is located in Wuhan, and is making every effort to fight against the epidemic in a special period. The health of Germany exhibition has been given the greatest satisfaction in terms of employee protection and remuneration.

In addition, in order to further expand production capacity, Germany exhibition health allocated the more than 5000 square meters of existing plant and production line transformation of Jialin pharmaceutical company to expand the production of Yangtze River pulse, and can expand the capacity of three times on the existing basis in the near future.

In view of the current domestic epidemic situation, it is very important to develop effective therapeutic drugs rapidly. The Honghui new medicine, a subsidiary of German health promotion, is actively promoting the research and development of antiviral drugs.

It is reported that Honghui new medicine currently accumulates research results of antiviral drugs, including macrolides and nucleotides. Hong Huixin pharmaceutical plans to use dozens of such leading compounds currently available to directly screen new anti coronavirus activity. If the activity is significant, it means that the compounds have better conditions of preparation. The structural modification, optimization, and early ADME and toxicity studies of Hong Huixin medical technology company, together with its experience in drug CMC, will shorten the time of entry into clinical research.

"I believe that enterprises that are willing to contribute and practise corporate social responsibility can win the recognition and welcome of the masses and customers, but also a force that can not be ignored by society." Zhang Yong told the "elite" reporter that the German exhibition health will continue to actively carry out corporate social responsibility and be a responsible and effective national enterprise, which will be a cornerstone for the healthy development of Germany and Germany.